TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 185 filers reported holding TG THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.21 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $3,713,537 | -77.6% | 444,203 | -33.3% | 0.00% | -83.3% |
Q2 2023 | $16,545,203 | +472.5% | 666,071 | +246.6% | 0.01% | +500.0% |
Q1 2023 | $2,890,117 | -64.7% | 192,162 | -72.3% | 0.00% | -75.0% |
Q4 2022 | $8,196,439 | +173.7% | 692,852 | +36.9% | 0.00% | +300.0% |
Q3 2022 | $2,995,000 | +53.8% | 505,918 | +10.4% | 0.00% | 0.0% |
Q2 2022 | $1,947,000 | -75.9% | 458,160 | -46.0% | 0.00% | -66.7% |
Q1 2022 | $8,067,000 | -27.8% | 848,220 | +44.3% | 0.00% | 0.0% |
Q4 2021 | $11,170,000 | -52.0% | 587,899 | -16.0% | 0.00% | -66.7% |
Q3 2021 | $23,293,000 | +3.9% | 699,904 | +21.1% | 0.01% | 0.0% |
Q2 2021 | $22,422,000 | +6.4% | 578,020 | +32.2% | 0.01% | -10.0% |
Q1 2021 | $21,075,000 | -15.4% | 437,251 | -8.7% | 0.01% | -23.1% |
Q4 2020 | $24,902,000 | +111.8% | 478,701 | +8.9% | 0.01% | +85.7% |
Q3 2020 | $11,760,000 | +31.6% | 439,482 | -4.2% | 0.01% | 0.0% |
Q2 2020 | $8,936,000 | +783.0% | 458,701 | +346.0% | 0.01% | +600.0% |
Q1 2020 | $1,012,000 | +98.4% | 102,839 | +123.9% | 0.00% | – |
Q4 2019 | $510,000 | +220.8% | 45,922 | +61.9% | 0.00% | – |
Q3 2019 | $159,000 | -41.1% | 28,358 | -9.4% | 0.00% | – |
Q2 2019 | $270,000 | +41.4% | 31,305 | +32.1% | 0.00% | – |
Q1 2019 | $191,000 | -44.5% | 23,700 | -61.4% | 0.00% | – |
Q3 2018 | $344,000 | -68.1% | 61,400 | -25.1% | 0.00% | -100.0% |
Q2 2018 | $1,078,000 | +87.8% | 82,000 | +103.0% | 0.00% | +200.0% |
Q1 2018 | $574,000 | +218.9% | 40,400 | +167.8% | 0.00% | 0.0% |
Q4 2015 | $180,000 | -22.4% | 15,084 | -30.7% | 0.00% | -50.0% |
Q3 2014 | $232,000 | -75.5% | 21,755 | -78.4% | 0.00% | -83.3% |
Q2 2014 | $946,000 | – | 100,759 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
M28 Capital Management LP | 726,200 | $3,086,000 | 3.46% |
Paradigm Biocapital Advisors LP | 1,964,709 | $8,350,000 | 1.66% |
683 Capital Management, LLC | 3,300,000 | $14,025,000 | 0.99% |
MAVERICK CAPITAL LTD | 6,747,549 | $28,677,000 | 0.71% |
Antara Capital LP | 1,500,000 | $6,375,000 | 0.27% |
Parkwood LLC | 47,168 | $1,375,000 | 0.24% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,677,500 | $11,379,000 | 0.24% |
PURA VIDA INVESTMENTS, LLC | 950,813 | $4,041,000 | 0.24% |
OCCUDO QUANTITATIVE STRATEGIES LP | 567,576 | $2,412,000 | 0.20% |
Antara Capital LP | 900,000 | $3,825,000 | 0.16% |